
Christian Angermayer on the Enhanced Olympics, Biotech Breakthroughs, and the Psychedelics Resurgence
About this episode
Step into the future of sports and biotech with our latest episode featuring Christian Angermayer, a visionary investor at the forefront of groundbreaking developments. We're unpacking the Enhanced Games, a bold reimagining of the Olympics that invites cutting-edge technology and regulated doping into the arena. Imagine a world where athletes optimize their performance with the full backing of science, competing in a landscape that values their hard work with proper compensation. Christian's insights challenge the status quo and paint a vivid picture of a world where AI and robotics unlock a new realm of human potential and leisure.
The landscape of personal wellness is rapidly shifting, and this episode delves into how societal evolution, spurred by movements like the queer and trans communities, is influencing the biotech and pharma sectors. Join us as we discuss the personalization of medicine, where choosing treatments extends beyond clinical needs to personal identity and aspirations. We explore the burgeoning success of drugs for weight management and body image, and I share my intrigue with the biotech industry's forays into performance enhancement and longevity. Christian and I navigate these complex topics, examining how they're poised to shape society's future norms and expectations.
For those with an eye on the biotech industry's pulse, this conversation sheds light on the resilience and innovation of companies leading the charge in psychedelics, like Atai and Compass. Despite economic headwinds, we explore the promise of a resurgence for these trailblazers in the coming year. Christian provides a wealth of knowledge on the strategic importance of owning patents and steering through the FDA's approval labyrinth. Beyond the business implications, we're exploring the profound potential of this work to reimagine human existence and enhance the way we interact with the world around us. This episode isn't just a conversation—it's a glimpse into the blueprint of tomorrow's human experience.
Nothing on this channel should be considered as personalized financial advice or a solicitation to buy or sell any securities.
The content in this program is for informational purposes only. You should not construe any information or other material as investment, financial, tax, or other advice. The views expressed by the participants are solely their own. A participant may have taken or recommended any investment position discussed, but may close such position or alter its recommendation at any time without notice. Nothing contained in this program constitutes a solicitation, recommendation, endorsement, or offer to buy or sell any securities or other financial instruments in any jurisdiction. Please consult your own investment or financial advisor for advice related to all investment decisions.
Sign up to The Lead-Lag Report on Substack and get 30% off the annual subscription today by visiting http://theleadlag.report/leadlaglive.
Get every episode summarized
Each time Lead-Lag Live publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Lead-Lag Live

Jeremy Schwartz, WisdomTree CIO: Growth vs Value, Home Bias & the Next 20 Years
Lead-Lag Live

Where the Next Decade of Alpha Lives Outside the US | Hervé Van Caloen, Mercator...
Lead-Lag Live

Smart Beta Meets China: Building Better Factor Exposure | Jason Hsu, Fujia Liu &...
Lead-Lag Live

The Rate-Cut Divergence Nobody's Pricing In | Live Sector Scans with TrendSpider...
Lead-Lag Live